Clinical Outcomes And Immune Responses In A Phase I/Ii Study Of Personalized, Neoantigen-Directed Immunotherapy In Patients With Advanced Mss-Crc, Gea And NsclcD. V. Catenacci,C-Y. Liao,S. Maron,B. J. Solomon,A. Mahipal,M. L. Johnson,D. Carbone, B. S. Henick,B. Johnson,S. Roychowdhury,K. Mody, D. H. Ahn, E. Bournazou,D. Schenk, S. Kounlavouth, L. Kraemer, G. Talbot, R. Rousseau,A. R. Ferguson,A. SpiraANNALS OF ONCOLOGY（2021）引用 7|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
